Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial

1. San-Miguel, J.F.
2. Hungria, V.T.M.
3. Yoon, S.-S.
4. Beksac, M.
5. Dimopoulos, M.A.
6. Elghandour, A.
7. Jedrzejczak, W.W.
8. Günther, A.
9. Nakorn, T.N.
10. Siritanaratkul, N.
11. Schlossman, R.L.
12. Hou, J.
13. Moreau, P.
14. Lonial, S.
15. Lee, J.H.
16. Einsele, H.
17. Sopala, M.
18. Bengoudifa, B.-R.
19. Binlich, F.
20. Richardson, P.G.